CN Patent

CN104906501A — 治疗银屑病的中药组分组合物

Assigned to SECOND AFFILIATED HOSPITAL OF GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Expires 2015-09-16 · 11y expired

What this patent protects

本发明公开了一种治疗银屑病的中药组分组合物，由莪术油和落新妇苷组成，本发明的治疗银屑病的中药组合物，可有效改善患者的皮损状况而不影响其免疫功能，兼具活血化瘀、清热解毒、及免疫调节作用，长期应用没有严重的毒副作用。

USPTO Abstract

本发明公开了一种治疗银屑病的中药组分组合物，由莪术油和落新妇苷组成，本发明的治疗银屑病的中药组合物，可有效改善患者的皮损状况而不影响其免疫功能，兼具活血化瘀、清热解毒、及免疫调节作用，长期应用没有严重的毒副作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN104906501A
Jurisdiction
CN
Classification
—
Expires
2015-09-16
Drug substance claim
No
Drug product claim
No
Assignee
SECOND AFFILIATED HOSPITAL OF GUANGZHOU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.